| Modality | Indication | Current Stage | Development Partners | ||||
|---|---|---|---|---|---|---|---|
| Discovery | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | |||
| Cancer | |||||||
| Vaccine | Breast Cancer |
|
|
|
|
||
| Vaccine | Ovarian Cancer |
|
|
|
|||
| Vaccine | Lung, Colon, and Prostate Cancers |
|
|
||||
| CAR-T | Ovarian Cancer |
|
|
|
|
||
| CAR-T | Other solid tumors |
|
|
||||
Latest News & Events
Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines
Read More...Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine
Read More...Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th
Read More...